1. Canada Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Indiva Limited

Indiva Limited

NDVAF
Indiva LimitedUS flagOther OTC
0.02
USD
+0.00
- -
4.60MMarket Cap
Indiva Limited
NDVAF
(Other OTC)

Recent

price

0.02

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2016
2017
2017
2018
2019
2020
2021
2022
2023
TTM
FRC
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.01
0.15
0.24
0.26
0.22
0.21
Revenue per Share
-37.85
-1.58
-1.13
-0.86
-4.97
-2.72
-0.53
-0.05
-0.35
-0.08
-0.11
-0.14
-0.16
-0.11
-0.08
-0.03
-0.03
Basic EPS, GAAP
-16.21
-1.6
-2.49
-1.8
-3.89
-1.56
-0.66
-0.17
-0.18
-0.13
-0.17
-0.26
-0.1
-0.15
- -
- -
-0.01
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-281.88
-155.5
-148.96
-112.34
-52.39
-45.57
-22.09
-0.06
-12.33
0.38
0.29
0.14
0.01
0.01
-0.07
-0.07
-0.08
Book Value per Share
-2.69
-3.05
-0.12
-0.81
2.95
0.16
0.18
0.11
0.04
0.49
0.37
0.23
0.1
0.08
- -
-0.01
-0.02
Tangible Book Value per Share
- -
- -
- -
- -
- -
- -
1
21
1
38
80
83
96
134
135
169
177
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
15
32
34
38
37
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-13,121.8
-1,033.13
-78.72
-20.65
-17.73
-5.66
-4.46
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
- -
- -
- -
- -
- -
Depreciation Expense
-1
- -
- -
- -
-1
-1
- -
-1
- -
-3
-9
-11
-15
-15
-11
-5
-4
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-14,623.68
-1,233.72
-105.27
-47.25
-31.78
-13.09
-11.83
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
22
16
-6
-12
7
-2
-5
-6
Working Capital
- -
- -
- -
- -
- -
- -
- -
1
- -
8
- -
2
3
21
22
19
19
LT Debt
- -
- -
- -
- -
1
- -
- -
2
- -
19
29
19
11
12
2
- -
-1
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-45.52
-66
-240
-1,635.08
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'23
Dec'23
Mar'24
ST Debt
- -
3
3
LT Borrowings
21
19
19
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
186
186
195
Market Capitalization
6
14
14

Working Capital

FRC

•

in mil. unless spec.
Sep'23
Dec'23
Mar'24
Total Current Assets
13
13
13
Cash, Cash Equivalents & STI
4
2
3
Accounts Receivable, Net
4
5
4
Inventories
4
5
5
Total Current Liabilities
15
18
19
Payables & Accruals
15
15
16
ST Debt
- -
3
3
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
5,044.76%
-53.42%
-115.96%
Free Cash Flow
313.12%
-47.36%
-250.35%
Net Income, GAAP
99.21%
-3.11%
-55.01%
Sales/Revenue/Turnover
- -
621.23%
9.21%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
9
8
8
9
34
2023
9
8
10
11
38
2024
9
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
-0.02
-0.02
-0.02
- -
-0.08
2023
-0.02
-0.01
- -
- -
-0.03
2024
-0.01
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
Similar Companies
China Infrastructure Construction Corp. (CHNC)
Zhejiang Xianju Pharmaceutical Co.,Ltd. (002332.SZ)
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (300534.SZ)
Whan In Pharm Co.,Ltd. (016580.KS)
MGC Pharmaceuticals Limited (MXC.L)
Caplin Point Laboratories Limited (CAPLIPOINT.NS)
Business
Indiva Limited (TSX-V:NDVA, OTCQX:NDVAF) is a Canadian licensed producer that manufactures, processes and distributes premium cannabis edibles, extracts, vapes, capsules, tablets and pre-rolls for the recreational and medical markets; its core brands include Pearls by Grön gummies, Bhang Chocolate bars, No Future products, Wana gummies, Indiva Doppio sandwich cookies, Indiva Blips, Indiva 1432 chocolates and Indiva Life extracts such as THC/CBD/CBG oils; the company operates a 40,000 square foot state-of-the-art production facility in London, Ontario, where it produces a portfolio of seven brands encompassing 53 SKUs and holds the leading national market share in the edibles category; founded in 2015 and headquartered in London, Ontario, Indiva supplies products across all Canadian provinces including Ontario, British Columbia, Alberta, Quebec, Nova Scotia, Saskatchewan, Manitoba, New Brunswick, Prince Edward Island and Newfoundland; in a major strategic development, SNDL Inc. completed its acquisition of Indiva's business and assets in November 2024 following a successful stalking horse bid in Indiva's CCAA proceedings, integrating Indiva's facility and brand portfolio to position SNDL as Canada's leading edibles producer and enhancing capacity utilization while reducing corporate expenses.

Company News

APIChatGPT

  • seekingalpha.com

    Indiva Limited (NDVAF) Q1 2024 Earnings Call Transcript

  • businesswire.com

    Indiva Provides Corporate Update Including Improved Fourth Quarter Revenue Guidance

  • seekingalpha.com

    Indiva Limited (NDVAF) Q3 2023 Earnings Call Transcript

  • businesswire.com

    Indiva to Report Third Quarter Results Pre-Market on Tuesday, November 21, 2023

  • seekingalpha.com

    Indiva Limited (NDVAF) Q2 2023 Earnings Call Transcript

  • businesswire.com

    Indiva to Report Second Quarter Results Pre-Market on Tuesday, August 29, 2023

  • seekingalpha.com

    Indiva Limited (NDVAF) Q4 2022 Earnings Call Transcript

  • businesswire.com

    Indiva to Report Fourth Quarter and Full Year Results Pre-Market on Tuesday April 18, 2023

  • seekingalpha.com

    Indiva Limited (NDVAF) Q3 2022 Earnings Call Transcript

  • seekingalpha.com

    Indiva Limited (NDVAF) CEO Niel Marotta on Q2 2022 Results - Earnings Call Transcript

  • prnewswire.com

    INDIVA TO REPORT SECOND QUARTER RESULTS PRE-MARKET ON TUESDAY, AUGUST 16, 2022

  • seekingalpha.com

    Indiva Limited (NDVAF) CEO Carmine Marotta on Q1 2022 Results - Earnings Call Transcript

  • seekingalpha.com

    Indiva's (NDVAF) CEO Niel Marotta on Q4 2021 Results - Earnings Call Transcript

  • seekingalpha.com

    Alan Brochstein On Cannabis Investing In 2022 (Video Transcript)

  • benzinga.com

    Oregon's Grön's Edibles Producer Enters Into Deal With Indiva Limited Of Canada

  • benzinga.com

    Indiva Limited Sees 143% YoY Spike In Q3 Revenue, Maintains Leading Market Share In Edibles Category

  • seekingalpha.com

    Indiva Limited (NDVAF) CEO Niel Marotta on Q3 2021 Results - Earnings Call Transcript

  • prnewswire.com

    Indiva to Report Third Quarter Results Pre-market on Tuesday November 16th

  • benzinga.com

    This Canadian Cannabis Company Experienced a Substantial Climb in Net Revenue and Became a Top 10 LP from the Edible Boom

  • benzinga.com

    Indiva's Shares Jump On Additional $8.5M Investment From Sundial